Reviews on Recent Clinical Trials


Ludovico Abenavoli
University Magna Graecia


Become EABM
Become Reviewer

Recent Progress: Gynecologic Oncology Group Trials in Uterine Corpus Tumors

Volume:4   Issue: 2
Pp: 70-74
Louise P. King and David Scott Miller
DOI: 10.2174/157488709788186012

Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer

Volume:4   Issue: 2
Pp: 75-78
Akira Miyajima, Eiji Kikuchi, Takeo Kosaka and Mototsugu Oya
DOI: 10.2174/157488709788185996

A General Framework for the Evaluation of Clinical Trial Quality

Volume:4   Issue: 2
Pp: 79-88
Vance W. Berger and Sunny Y. Alperson
DOI: 10.2174/157488709788186021

Bisphosphonate Osteonecrosis (BON): Unanswered Questions and Research Possibilities

Volume:4   Issue: 2
Pp: 99-109
Cesar A. Migliorati, Mark M. Schubert and Douglas E. Peterson
DOI: 10.2174/157488709788185978

Chemoradiotherapy in Locally Advanced, Unresectable Non-Small Cell Lung Cancer

Volume:4   Issue: 2
Pp: 110-121
Lauren R. Mitchell, Jeffrey M. Albert and Bo Lu
DOI: 10.2174/157488709788185969

Evaluating the Antifracture Efficacy of Bisphosphonates

Volume:4   Issue: 2
Pp: 122-130
Michael Pazianas, Solomon Epstein and Mone Zaidi
DOI: 10.2174/157488709788186030